---
layout: talk_reveal3
title: Evolutionary dynamics of SARS-CoV-2
venue: Bill & Melinda Gates Foundation
event: COVID-19 Scenario Planning Workshop
author: Trevor Bedford
widescreen: true
---

<!-- ~15 min worth of slides -->

<!--
Outline:

- Evolutionary dynamics overview (Muller plots and evolution driving epidemiology)
- Tracking evolution via Nextstrain
- Early pandemic spread
- D614G and summer/fall variants
- Variants of concern, emergence and spread
- Current situation update
- Forecasts for antigenic evolution
- Scale of modern genomic surveillance (again comparisons to influenza)
- Data-driven vaccine updating
-->

<section data-background-iframe="/talks/viz/gradient/">
	<h2 class="title">{{ page.title }}</h2>
	<br>&nbsp;<br>
	<p class="title">
	Trevor Bedford (@trvrb)
	<br>
	Associate Professor, Fred Hutchinson Cancer Research Center
	<br>
	{{ page.date | date: "%-d %b %Y" }}
	<br>
	{{ page.event }}
	<br>
	{{ page.venue }}
	<br>&nbsp;<br>
	Slides at: bedford.io/talks
</section>

<section class="left-align">
	<h3>1. Real-time tracking of SARS-CoV-2 evolution</h3>
	<h3>2. Emergence of variants of concern</h3>
	<h3>3. Current circulation patterns</h3>
	<h3>4. Expectations for antigenic evolution</h3>
</section>

<section data-background="#000000">
	<h1 class="title">Real-time tracking of SARS-CoV-2 evolution</h1>
</section>

<section>
	<h3>Spike protein is critical for cell invasion by the virus and is the primary target for human immune response</h3>
	<img class="stretch" data-src="/images/talks/sars_cov_2_spike_structure.png">
	<div class="citation">
		<a href="https://science.sciencemag.org/content/367/6483/1260">Wrapp et al. 2020. Science.</a>
	</div>
</section>

<section>
	<h3>Over 1.4M SARS-CoV-2 genomes shared to GISAID and evolution tracked in real-time at nextstrain.org</h3>
	<img class="stretch" data-src="/images/talks/ncov_tree_map_2021_03_07_global.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>SARS-CoV-2 lineages establish globally in February and March</h3>
	<img class="stretch" src="/images/talks/ncov_tree_map_early_pandemic.png">
	<div class="citation">
		<a href="/papers/bedford-ncov-cryptic-transmission/">Bedford et al. 2020. Science.</a>
	</div>
</section>

<section>
	<h3>Limited early mutations like D614G spread globally during initial wave</h3>
	<img class="stretch" src="/images/talks/ncov_d614g_european_introduction.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h4 class="inset-top-right">
		After initial wave, with mitigation <br> efforts and decreased travel, <br> regional clades emerge
	</h4>
	<img class="stretch" src="/images/talks/ncov_tree_2020_10_20_global_jun_oct.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Mutations in summer and fall 2020 were confined to regional dominance</h3>
	<img class="stretch" data-src="/images/talks/ncov_a222v_tree_map.jpg">
	<div class="citation">
		<a href="https://www.medrxiv.org/content/10.1101/2020.10.25.20219063v1">Hodcroft et al. 2020. medRxiv.</a>
	</div>
</section>

<section data-background="#000000">
	<h1 class="title">Emergence of variants of concern</h1>
</section>

<section>
	<h3>484K and 501Y repeatedly emerging across the world</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_484K_501Y_2021_05_07.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/global?c=gt-S_484,501">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V1 (B.1.1.7) in the UK</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_clock_2021_02_10.png">
	<div class="citation">
		<a href="https://nextstrain.org/groups/neherlab/ncov/united-kingdom?c=clade_membership&f_country=United%20Kingdom&l=clock&r=division">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V2 (B.1.351) in the South Africa</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V2_clock_2021_02_10.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/africa?f_country=South%20Africa&l=clock&r=division">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V3 (P.1) in the Brazil</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V3_clock_2021_02_10.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/south-america?f_country=Brazil&l=clock&r=division">nextstrain.org</a>
	</div>
</section>

<!-- <section>
	<div class="left" style="float:left; width:54%">
		<h3>Substantial convergent evolution</h3>
	</div>
	<div class="right" style="float:right; width:44%">
		<img data-src="/images/talks/ncov_variants_shared_mutations_2021_02_05.png">
	</div>
	<div class="citation">
		<a href="https://covariants.org">covariants.org</a>
	</div>
</section> -->

<section class="left-align">
	<h3>
		Working hypothesis of within-host evolution occurring during prolonged infection,
		driven by natural selection for immune escape.
	</h3>
</section>

<section>
	<h3>Rapid within-host evolution during persistent infection</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_choi_chronic_tree.png">
	<div class="citation">
		<a href="https://www.nejm.org/doi/full/10.1056/NEJMc2031364">Choi et al. 2020. NEJM.</a>
	</div>
</section>

<section>
	<h3>484K and 501Y observed during this evolution</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_choi_chronic_alignment.png">
	<div class="citation">
		<a href="https://www.nejm.org/doi/full/10.1056/NEJMc2031364">Choi et al. 2020. NEJM.</a>
	</div>
</section>

<section data-background="#000000">
	<h1 class="title">Current circulation patterns</h1>
</section>

<section>
	<h3>VUI / VOC lineages are rapidly expanding across the world</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_emerging_lineages_2021_05_07.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/global?branchLabel=emerging_lineage&c=emerging_lineage">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>These lineages show excess mutations across the genome</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_scatter_divergence_2021_05_07.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/global?branchLabel=emerging_lineage&branches=hide&c=emerging_lineage&l=scatter">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>But show most substantial excess in the S1 domain of spike</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_scatter_s1_mutations_2021_05_07.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/global?branchLabel=emerging_lineage&branches=hide&c=emerging_lineage&l=scatter">nextstrain.org</a>
	</div>
</section>

<section data-background="#000000">
	<h1 class="title">Evolutionary rate in context</h1>
</section>

<section>
	<h3>Up to December, my expectation was evolution as seen in seasonal coronaviruses</h3>
	<img class="stretch" data-src="/images/talks/seasonal_cov_adaptation_accumulation_oc43_elife.png">
	<div class="citation">
		<a href="/papers/kistler-hcov-adaptive-evolution/">Kistler and Bedford. 2021. eLife.</a>
	</div>
</section>

<section>
	<h3>OC43 and 229E show flu B-like rates of adaptive evolution in S1</h3>
	<img class="stretch" data-src="/images/talks/seasonal_cov_adaptation_rate_comparison_elife.jpg">
	<div class="citation">
		<a href="/papers/kistler-hcov-adaptive-evolution/">Kistler and Bedford. 2021. eLife.</a>
	</div>
</section>

<section>
	<h3>SARS-CoV-2 evolves at a rate of ~3.0 subs per year in spike S1</h3>
	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_spike_clock_2021_05_07.png">
</section>

<section>
	<h3>Spike S1 rate of ~3.0 subs per year similar to rate in HA1 of flu A</h3>
	<img class="stretch" data-src="/images/talks/flu_mutation_rate_ha1_clock_across_subtypes.png">
</section>

<section>
	<h3>Influenza H3N2 drifts at ~1 two-fold HI dilution per year</h3>
	<img class="stretch" data-src="/images/talks/bmds_lineages_drift_stats.png">
	<div class="citation">
		<a href="http://bedford.io/papers/bedford-flux/">Bedford et al. 2014. eLife.</a>
	</div>
</section>

<section>
	<h3>
		501Y.V2 (B.1.351) shows an ~8-fold drop in neutralization titer, equivalent to ~3 years of H3N2 evolution
	</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V2_neutralization.png">
	<div class="citation">
		<a href="https://www.nature.com/articles/s41591-021-01285-x">Wibmer et al. 2021. Nat Med.</a>
	</div>
</section>

<section class="left-align">
	<h3>Three scenarios for ongoing viral evolution</h3>
	<p>
	<ol>
		<li>
			Seasonal coronavirus-like scenario: SARS-CoV-2 evolution slows after selection for replication completes.
			S1 is relatively inflexible in terms of antigenic evolution.
			New strains emerge rarely and replace existing diversity.
			Vaccine updates required every ~5 years.
		</li>
		<li>
			Influenza H3N2-like scenario: SARS-CoV-2 evolution slows after selection for replication completes, but
			S1 remains highly antigenically flexible.
			New strains emerge often and replace existing diversity.
			Vaccine updates required every 1-2 years.
		</li>
		<li>
			HIV-like scenario: SARS-CoV-2 evolution slows after selection for replication completes, but S1 remains
			highly antigenically flexible.
			New strains emerge and co-circulate leading to continual antigenic diversification.
			Vaccine updates cannot cover diversity of circulating viruses.
		</li>
	</ol>
	</p>
</section>

<section>
	<h3>Acknowledgements</h3>

	<p class="even-smaller">
		<b>SARS-CoV-2 genomic epi</b>: Data producers from all over the world, GISAID and the Nextstrain team
	</p>

	<p class="tiny"><b>Bedford Lab</b>:
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/allison-black.jpg"> Alli Black,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/john-huddleston.jpg"> John Huddleston,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/james-hadfield.jpg"> James Hadfield,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/katie-kistler.jpg"> Katie Kistler,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/louise-moncla.jpg"> Louise Moncla,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/maya-lewinsohn.jpg"> Maya Lewinsohn,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/thomas-sibley.jpg"> Thomas Sibley,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jover-lee.jpg"> Jover Lee,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/kairsten-fay.jpg"> Kairsten Fay,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/misja-ilcisin.jpg"> Misja Ilcisin,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/cassia-wagner.jpg"> Cassia Wagner,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/miguel-paredes.jpg"> Miguel Paredes,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/nicola-mueller.jpg"> Nicola MÃ¼ller,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/marlin-figgins.jpg"> Marlin Figgins,</span>
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/eli-harkins.jpg"> Eli Harkins</span>
	</p>

	<div class="pull-right" style="vertical-align: bottom; display: table-cell;">
		<img width="11%" data-src="/images/talks/logo_fred_hutch_vertical.png">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_pew.png">
		&nbsp; &nbsp;
		<img width="14%" data-src="/images/talks/logo_bmgf.png">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_gates_ventures.png">
		&nbsp; &nbsp;
		<img width="11%" data-src="/images/talks/logo_wellcome_trust.jpg">
		&nbsp; &nbsp;
		<img width="7%" data-src="/images/talks/logo_nih.jpg">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_osp.jpg">
	</div>
</section>
